文献速递遗传性与小管间质肾病慢性肾脏病

常染色体显性肾小管间质性肾病:ADTKD-UMOD与ADTKD-MUC1的临床表现

Autosomal Dominant Tubulointerstitial Kidney Disease: Clinical Presentation of Patients With ADTKD-UMOD and ADTKD-MUC1.
PubMed 文献 · Am J Kidney Dis · 2018-05-18

这项西班牙回顾性队列研究纳入56个家系(131例患者),对UMOD、MUC1、REN、HNF1B进行基因检测。25个家系确诊ADTKD,其中MUC1致病突变c.(428)dupC是最主要遗传原因,且MUC1突变者进展至终末期肾病的风险更高,但两型临床表现难以区分,高尿酸血症在UMOD突变者中更常见。

要点

  • 西班牙ADTKD队列中MUC1突变c.(428)dupC是最主要遗传原因。
  • MUC1突变者进展至ESRD风险高于UMOD突变者(HR 2.24)。
  • UMOD突变者高尿酸血症患病率显著高于MUC1突变者。

核心结论

  • 西班牙ADTKD队列中最主要遗传原因为MUC1致病突变c.(428)dupC。
  • MUC1突变者肾脏生存可能劣于UMOD突变者,但临床表现无法区分两型。
  • 高尿酸血症和痛风在ADTKD-UMOD者中更常见。

研究设计与样本

  • 回顾性队列研究,纳入来自西班牙不同医院的56个家系(131例受累个体)。
  • 收集临床、实验室、影像学和病理数据,并对UMOD、MUC1、REN和HNF1B进行基因检测。

主要发现

  • 25个家系(45%)确诊ADTKD:9个携带UMOD致病变异(41例),16个携带MUC1致病突变c.(428)dupC(90例)。
  • REN和HNF1B未发现致病变异。
  • 77例发生ESRD者中,ADTKD-MUC1中位ESRD年龄51岁 vs ADTKD-UMOD 56岁(P=0.1)。
  • MUC1重复突变者发生ESRD风险更高(HR 2.24;P=0.03)。
  • eGFR下降斜率两组无显著差异(UMOD组-3.0 mL/min/1.73m2/年 vs MUC1组-3.9 mL/min/1.73m2/年;P=0.2)。

临床怎么用

  • 对疑似ADTKD患者应进行UMOD和MUC1基因检测,尤其MUC1 c.(428)dupC。
  • UMOD突变者需关注高尿酸血症和痛风,MUC1突变者可能需更密切监测肾功能。

局限性

  • 西班牙队列相对较小。
  • MUC1分析仅限胞嘧啶重复突变。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

RATIONALE & OBJECTIVE: Autosomal dominant tubulointerstitial kidney disease (ADTKD) is a rare underdiagnosed cause of end-stage renal disease (ESRD). ADTKD is caused by mutations in at least 4 different genes: MUC1, UMOD, HNF1B, and REN. STUDY DESIGN: Retrospective cohort study. SETTING & PARTICIPANTS: 56 families (131 affected individuals) with ADTKD referred from different Spanish hospitals. Clinical, laboratory, radiologic, and pathologic data were collected, and genetic testing for UMOD, MUC1, REN, and HNF1B was performed. PREDICTORS: Hyperuricemia, ultrasound findings, renal histology, genetic mutations. OUTCOMES: Age at ESRD, rate of decline in estimated glomerular filtration rate. RESULTS: ADTKD was diagnosed in 25 families (45%), 9 carried UMOD pathogenic variants (41 affected members), and 16 carried the MUC1 pathogenic mutation c.(428)dupC (90 affected members). No pathogenic variants were identified in REN or HNF1B. Among the 77 individuals who developed ESRD, median age at onset of ESRD was 51 years for those with ADTKD-MUC1 versus 56 years (P=0.1) for those with ADTKD-UMOD. Individuals with the MUC1 duplication presented higher risk for developing ESRD (HR, 2.24; P=0.03). The slope of decline in estimated glomerular filtration rate showed no significant difference between groups (-3.0mL/min/1.73m2 per year in the ADTKD-UMOD group versus -3.9mL/min/1.73m2 per year in the ADTKD-MUC1 group; P=0.2). The prevalence of hyperuricemia was significantly higher in individuals with ADTKD-UMOD (87% vs 54%; P=0.006). Although gout occurred more frequently in this group, the difference was not statistically significant (24% vs 7%; P=0.07). LIMITATIONS: Relatively small Spanish cohort. MUC1 analysis limited to cytosine duplication. CONCLUSIONS: The main genetic cause of ADTKD in our Spanish cohort is the MUC1 pathogenic mutation c.(428)dupC. Renal survival may be worse in individuals with the MUC1 mutation than in those with UMOD mutations. Clinical presentation does not permit distinguishing between these variants. However, hyperuricemia and gout are more frequent in individuals with ADTKD-UMOD.

来源:Am J Kidney Dis,查看原文。版权归原作者所有。

引用

  1. Ayasreh N, Bullich G, Miquel R, et al. Autosomal Dominant Tubulointerstitial Kidney Disease: Clinical Presentation of Patients With ADTKD-UMOD and ADTKD-MUC1. Am J Kidney Dis. 2018. PMID: 29784615. doi:10.1053/j.ajkd.2018.03.019

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。